CLOVIS ONCOLOGY INC (CLVS)

US1894641000 - Common Stock

0.0812  0 (-5.58%)

After market: 0.078 0 (-3.94%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
143M
49.90%		164.5M
15.03%		148.757M
-9.57%		131.8M
-11.40%
EBITDA
YoY % growth
-359.53M
-9.21%		-293.9M
18.25%		-211.795M
27.94%		-186.66M
11.87%
EBIT
YoY % growth
-367.3M
-10.04%		-302.1M
17.75%		-220.291M
27.08%		-199.327M
9.52%
Operating Margin
-256.85%-183.65%-148.09%-151.23%
EPS
YoY % growth
-7.49
-5.94%		-4.34
42.06%		-2.29
47.24%		-1.64
28.29%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 22
EPS
Q2Q % growth		-0.32
34.13%
Revenue
Q2Q % growth		32.17M
-10.56%
EBITDA
Q2Q % growth		-38.76M
EBIT
Q2Q % growth		-41.557M
21.16%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth		 -0.39
30.36%		-0.420.037.49%
Q2 2022
Q2Q % growth		 -0.50
18.03%		-0.42-0.08-18.60%
Q1 2022
Q2Q % growth		 -0.44
31.25%		-0.440.000.26%
Q4 2021
Q2Q % growth		 -0.48
52.94%		-0.580.1017.44%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth		 30.663M
-19.13%		33.885M-3.222M-9.51%
Q2 2022
Q2Q % growth		 32.143M
-12.70%		37.771M-5.628M-14.90%
Q1 2022
Q2Q % growth		 34.247M
-9.99%		37.715M-3.468M-9.20%
Q4 2021
Q2Q % growth		 35.968M
-16.93%		38.406M-2.438M-6.35%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% N/A 9.3% N/A
Revenue0% N/A -3.44% N/A